Adam Olszewski
Adam Olszewski
Associate Professor, Brown University Alpert Medical School
Verified email at - Homepage
Cited by
Cited by
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
M Li, VO Ona, C Guégan, M Chen, V Jackson-Lewis, LJ Andrews, ...
Science 288 (5464), 335, 2000
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
AJ Olszewski, JJ Castillo
Cancer 119 (3), 629-638, 2013
Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis
KD Bishop, AJ Olszewski
International journal of cancer 134 (12), 2961-2971, 2014
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
Outcomes of patients with double-hit lymphoma who achieve first complete remission
DJ Landsburg, MK Falkiewicz, J Maly, KA Blum, C Howlett, T Feldman, ...
Journal of Clinical Oncology 35 (20), 2260, 2017
Sites of extranodal involvement are prognostic in patients with diffuse large B‐cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end …
JJ Castillo, ES Winer, AJ Olszewski
American journal of hematology 89 (3), 310-314, 2014
Overall survival and competing risks of death in patients with W aldenström macroglobulinaemia: an analysis of the S urveillance, E pidemiology and E nd R esults database
JJ Castillo, AJ Olszewski, S Kanan, K Meid, ZR Hunter, SP Treon
British Journal of Haematology 169 (1), 81-89, 2015
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study
DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ...
Cancer discovery 10 (10), 1514-1527, 2020
Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence
TA Ollila, AJ Olszewski
Current treatment options in oncology 19, 1-20, 2018
Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis
H Shafqat, S Ali, M Salhab, AJ Olszewski
Diseases of the Colon & Rectum 58 (3), 294-303, 2015
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base
AJ Olszewski, R Shrestha, JJ Castillo
Journal of Clinical Oncology 33 (6), 625-633, 2015
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database
JJ Castillo, AJ Olszewski, AM Cronin, ZR Hunter, SP Treon
Blood, The Journal of the American Society of Hematology 123 (25), 3999-4000, 2014
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia
TW LeBlanc, PC Egan, AJ Olszewski
Blood, The Journal of the American Society of Hematology 132 (7), 717-726, 2018
Population‐based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database
JJ Castillo, ES Winer, AJ Olszewski
Cancer 119 (20), 3672-3679, 2013
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ...
Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021
Antibody response to COVID-19 vaccination in adults with hematologic malignant disease
TA Ollila, S Lu, R Masel, A Zayac, K Paiva, RD Rogers, AJ Olszewski
JAMA oncology 7 (11), 1714-1716, 2021
Adjuvant therapy for resected gallbladder cancer: analysis of the National Cancer Data Base
KC Mantripragada, F Hamid, H Shafqat, AJ Olszewski
Journal of the National Cancer Institute 109 (2), djw202, 2017
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma
JJ Castillo, T Guerrero-Garcia, F Baldini, E Tchernonog, G Cartron, ...
British journal of haematology 184 (4), 679-682, 2019
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
TA Ollila, I Sahin, AJ Olszewski
OncoTargets and therapy 12, 1085, 2019
The system can't perform the operation now. Try again later.
Articles 1–20